Run‐Ling Wang

2.3k citations

77 papers · 1.2k indexed · h-index 20

Impact in

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Computational Theory and Mathematics top 5%
- Computational Drug Discovery Methods

Papers in ⓘ

Molecular Biology 59
- Protein Tyrosine Phosphatases 38
- ATP Synthase and ATPases Research 10
- Peroxisome Proliferator-Activated Receptors 7
- Receptor Mechanisms and Signaling 6
Immunology 23
- Galectins and Cancer Biology 22

Co-authors: Ying Ma (38 shared papers)Weiren Xu (21 shared papers)Shuqing Wang (13 shared papers)Kuo‐Chen Chou (2 shared papers)Xian‐Chao Cheng (17 shared papers)Hua Sun (6 shared papers)Peng Yu (6 shared papers)Weiya Li (20 shared papers)
Journals: Journal of Biomolecular Structure and Dynamics (14 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Oncotarget (5 papers)Journal of Molecular Graphics and Modelling (3 papers)Bioorganic Chemistry (3 papers)
Partner nations: China New Zealand United States

In The Last Decade

Run‐Ling Wang

76 papers receiving 1.2k citations

Peers

Countries citing papers authored by Run‐Ling Wang

Since Specialization

Citations

This map shows the geographic impact of Run‐Ling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run‐Ling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run‐Ling Wang more than expected).

Fields of papers citing papers by Run‐Ling Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Run‐Ling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run‐Ling Wang. The network helps show where Run‐Ling Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Run‐Ling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Run‐Ling Wang Line = papers co-authored together Run‐Ling Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Natural Prenylchalconaringenins and Prenylnaringenins as Antidiabetic Agents: α-Glucosidase and α-Amylase Inhibition and in Vivo Antihyperglycemic and Antihyperlipidemic Effects Journal of Agricultural and Food Chemistry ·Hua Sun, Dong Wang, Xiaotong Song, Yazhou Zhang, Weina Ding, Xiaolin Peng, Xiaoting Zhang, Yashan Li, Ying Ma, Run‐Ling Wang, Peng Yu	2017	106
2	Novel Inhibitor Design for Hemagglutinin against H1N1 Influenza Virus by Core Hopping Method PLoS ONE ·Xiaobo Li, Shuqing Wang, Weiren Xu, Run‐Ling Wang, Kuo‐Chen Chou	2011	99
3	Design Novel Dual Agonists for Treating Type-2 Diabetes by Targeting Peroxisome Proliferator-Activated Receptors with Core Hopping Approach PLoS ONE ·Ying Ma, Shuqing Wang, Weiren Xu, Run‐Ling Wang, Kuo‐Chen Chou	2012	98
4	Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones Bioorganic & Medicinal Chemistry Letters ·Hua Sun, Yashan Li, Xiaoting Zhang, Yanan Lei, Weina Ding, Xue Zhao, Haomeng Wang, Xiaotong Song, Qingwei Yao, Yongmin Zhang, Ying Ma, Run‐Ling Wang, Tao Zhu, Peng Yu	2015	54
5	Synthesis of 6-hydroxyaurone analogues and evaluation of their α-glucosidase inhibitory and glucose consumption-promoting activity: Development of highly active 5,6-disubstituted derivatives Bioorganic & Medicinal Chemistry Letters ·Hua Sun, Weina Ding, Xiaotong Song, Dong Wang, Mingzhu Chen, Kaili Wang, Yazhou Zhang, Peng Yuan, Ying Ma, Run‐Ling Wang, Robert H. Dodd, Yongmin Zhang, Kui Lu, Peng Yu	2017	48
6	Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines European Journal of Medicinal Chemistry ·Shukkoor Muhammed Kondengaden, Liufei Luo, Kenneth Huang, Mengyuan Zhu, Lanlan Zang, Eudoxie Bataba, Run‐Ling Wang, Cheng Luo, Binghe Wang, Keqin Kathy Li, Peng George Wang	2016	38
7	Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors European Journal of Medicinal Chemistry ·Hua Sun, Yazhou Zhang, Weina Ding, Xue Zhao, Xiaotong Song, Dong Wang, Yashan Li, Kailin Han, Yang Yang, Ying Ma, Run‐Ling Wang, Peng Yu	2016	37
8	Three new powerful oseltamivir derivatives for inhibiting the neuraminidase of influenza virus Biochemical and Biophysical Research Communications ·Shuqing Wang, Xian‐Chao Cheng, Wei‐Li Dong, Run‐Ling Wang, Kuo‐Chen Chou	2010	31
9	The Discovery of a Novel and Selective Inhibitor of PTP1B Over TCPTP: 3D QSAR Pharmacophore Modeling, Virtual Screening, Synthesis, and Biological Evaluation Chemical Biology & Drug Design ·Ying Ma, Yuanyuan Jin, Ye‐Liu Wang, Run‐Ling Wang, Xinhua Lu, Dexin Kong, Weiren Xu	2014	31
10	Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout Bioorganic & Medicinal Chemistry Letters ·Jingwei Wu, Ling Yin, Yuqiang Liu, Huan Zhang, Yafei Xie, Run‐Ling Wang, Guilong Zhao	2018	29
11	Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors European Journal of Medicinal Chemistry ·Meiyan Wang, Yuanyuan Jin, Hui‐Yu Wei, Lisong Zhang, Su‐Xia Sun, Xiu‐Bo Chen, Wei‐Li Dong, Weiren Xu, Xian‐Chao Cheng, Run‐Ling Wang	2015	26
12	Multitargeted bioactive ligands for PPARs discovered in the last decade Chemical Biology & Drug Design ·Jun Zhang, Xin Liu, Xie Xian-bin, Xian‐Chao Cheng, Run‐Ling Wang	2016	26
13	Docking and Molecular Dynamics Simulations of Peroxisome Proliferator Activated Receptors Interacting with Pan Agonist Sodelglitazar Protein and Peptide Letters ·Xuyuan Liu, Run‐Ling Wang, Weiren Xu, Tang Li-da, Shuqing Wang, Kuo‐Chen Chou	2011	24
14	Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamics Computational Biology and Chemistry ·Wen-Yan Jin, Ying Ma, Weiya Li, Honglian Li, Run‐Ling Wang	2018	22
15	SAHA-based novel HDAC inhibitor design by core hopping method Journal of Molecular Graphics and Modelling ·Lanlan Zang, Xuejiao Wang, Xiaobo Li, Shuqing Wang, Weiren Xu, Xie Xian-bin, Xian‐Chao Cheng, Huan Ma, Run‐Ling Wang	2014	21
16	The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches Oncotarget ·Honglian Li, Ying Ma, Yu Li, Xiu‐Bo Chen, Wei‐Li Dong, Run‐Ling Wang	2017	21
17	Exploring the cause of the inhibitor 4AX attaching to binding site disrupting protein tyrosine phosphatase 4A1 trimerization by molecular dynamic simulation Journal of Biomolecular Structure and Dynamics ·Weiya Li, Yuqing Duan, Yangchun Ma, Xinhua Lu, Ying Ma, Run‐Ling Wang	2019	21
18	Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors Bioorganic & Medicinal Chemistry Letters ·Kailin Han, Yashan Li, Yazhou Zhang, Yuou Teng, Ying Ma, Meiyan Wang, Run‐Ling Wang, Weiren Xu, Qingwei Yao, Yongmin Zhang, Haijuan Qin, Hua Sun, Peng Yu	2015	20
19	Design, synthesis and evaluation of novel metalloproteinase inhibitors based on l-tyrosine scaffold Bioorganic & Medicinal Chemistry ·Xian‐Chao Cheng, Run‐Ling Wang, Zhen-Ke Dong, Jing Li, Yao-Yuan Li, Rongrong Li	2012	20
20	Exploring the effect of D61G mutation on SHP2 cause gain of function activity by a molecular dynamics study Journal of Biomolecular Structure and Dynamics ·Honglian Li, Ying Ma, Chang-Jie Zheng, Wen-Yan Jin, Wen‐Shan Liu, Run‐Ling Wang	2017	20

About Run‐Ling Wang

Run‐Ling Wang is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Toxicology and Oncology, having authored 77 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (38 papers), Galectins and Cancer Biology (22 papers), Bioactive Compounds and Antitumor Agents (15 papers), ATP Synthase and ATPases Research (10 papers), Synthesis and biological activity (9 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Receptor Mechanisms and Signaling (6 papers) and Computational Drug Discovery Methods (6 papers). The work is most often cited by research in Toxicology (95 citations), Computational Theory and Mathematics (193 citations), Molecular Biology (782 citations), Organic Chemistry (322 citations) and Endocrinology, Diabetes and Metabolism (181 citations). Run‐Ling Wang has collaborated with scholars based in China, New Zealand and United States. Frequent co-authors include Ying Ma, Weiren Xu, Shuqing Wang, Kuo‐Chen Chou, Xian‐Chao Cheng, Hua Sun, Peng Yu, Weiya Li, Wei‐Li Dong and Xiaobo Li. Their work appears in journals such as Journal of Biomolecular Structure and Dynamics, Bioorganic & Medicinal Chemistry Letters, Oncotarget, Journal of Molecular Graphics and Modelling and Bioorganic Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact